AMTI Applied Molecular Transport Inc.

Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases.

$1.00  -0.05 (-4.76%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/05/2020
Outstanding shares:  38,943,097
Average volume:  173,340
Market cap:   $40,890,252
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMFYGD5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.32
PS ratio:   0.00
Return on equity:   -95.74%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy